Generic Competition and Pricing Pressure: ANIP's generic product portfolio is highly susceptible to intense competition and price erosion from other generic manufacturers, potentially reducing profitability and market share.

Regulatory Approval and Compliance Challenges: The company's ability to market products relies on obtaining and maintaining regulatory approvals (e.g., FDA) and adhering to strict manufacturing and quality standards, with non-compliance leading to costly delays, recalls, or penalties.

Intellectual Property Litigation Risk: ANIP faces the risk of patent infringement lawsuits from competitors or challenges to its own patents, which could result in significant legal expenses, loss of product exclusivity, or inability to market certain products.